GP Bold 300

GP Bold 300 – Boldenone Undecylenate Overview

GP Bold 300 is an injectable anabolic steroid from Geneza Pharmaceuticals. The active substance is Boldenone Undecylenate at 300 mg/ml in a 10 ml vial. Users commonly search for this product as Equipoise, EQ, Bold 300, boldenone undecylenate, and EQ 300.

What Is Boldenone Undecylenate?

Boldenone Undecylenate is a long-ester injectable anabolic steroid derived from testosterone and structurally modified to produce a distinct profile. The Undecylenate ester is one of the longest esters attached to any commonly used anabolic steroid – longer than Enanthate or Cypionate – giving it a half-life of approximately 14 days and allowing once or twice-weekly injections for stable blood levels. Boldenone aromatizes to estrogen at approximately half the rate of testosterone, making estrogenic side effects less prominent than with equivalent testosterone doses but still relevant. The compound is associated with two consistently cited physiological effects: significantly increased appetite and elevated red blood cell production (hematocrit and hemoglobin increase), which are the primary reasons users search for its pharmacological context.

Why Users Search for GP Bold 300

Boldenone Undecylenate is searched primarily under the Equipoise and EQ brand names. The compound is discussed in lean bulking and recomposition contexts – its lower aromatization relative to testosterone, consistent appetite-stimulating effect, and vascularity-supporting RBC elevation are the primary cited characteristics. The most common comparison search is EQ vs Deca (Boldenone Undecylenate vs Nandrolone Decanoate) – both are long-ester injectables used in similar contexts but with different risk profiles: EQ has lower progestogenic activity than Deca, while Deca is more suppressive and associated with progestin-related side effects. Hematocrit monitoring is consistently highlighted as the most EQ-specific bloodwork concern.

• Active substance: Boldenone Undecylenate – long-ester injectable boldenone.
• Brand names: Equipoise, EQ – the dominant search terms for Boldenone Undecylenate.
• Ester / half-life: Undecylenate ester – approximately 14-day half-life; once or twice-weekly injection schedule.
• Aromatization: Aromatizes at approximately half the rate of testosterone – lower estrogenic activity, but AI may still be required.
• Key effects searched: Appetite increase and hematocrit/RBC elevation are the two most cited compound-specific effects.
• Primary comparison: EQ vs Deca – Boldenone Undecylenate vs Nandrolone Decanoate – the dominant community comparison search.

GP Bold 300 Dose and Concentration Information

GP Bold 300 is listed at 300 mg/ml. A 10 ml vial contains 3000 mg total Boldenone Undecylenate. The Undecylenate ester – the longest ester used on any common injectable anabolic – gives Boldenone Undecylenate an approximate half-life of 14 days. Once or twice-weekly injections are the standard reference for maintaining stable blood levels with GP Bold 300.

Ester Profile and Injection Schedule

The Undecylenate ester is longer than Enanthate or Cypionate esters used on testosterone. This extended release profile means blood levels build gradually and take time to stabilize, which is why community references consistently note that EQ cycles need to be long enough – typically 12-16 weeks in community discussions – to allow the compound to reach and maintain stable levels. PCT timing after a GP Bold 300 cycle follows the long ester clearance: approximately 14 days after the last injection, consistent with other long-ester injectables like GP Test Enanth 250 and GP Deca 300.

Bloodwork and Monitoring Context

Hematocrit and hemoglobin elevation are the most EQ-specific bloodwork concerns referenced across community sources. Boldenone Undecylenate increases red blood cell production more markedly than most other injectable anabolics, which is the basis for both the vascularity-related effects and the blood pressure and hematocrit monitoring requirement. Complete blood count (CBC) alongside standard lipid panel, blood pressure, and HPTA suppression markers are the consistent monitoring references for GP Bold 300 cycles. Estrogen monitoring is relevant due to aromatization at approximately half the testosterone rate – an aromatase inhibitor may be required depending on individual response.

• Concentration: 300 mg/ml – 3000 mg total Boldenone Undecylenate per 10 ml vial.
• Injection frequency: Once or twice weekly – Undecylenate ester with approximately 14-day half-life.
• Cycle length context: Long ester build-up requires sufficient cycle length – 12-16 weeks cited in community references.
• PCT start: Approximately 14 days post-last-injection – consistent with other long-ester injectables.
• Hematocrit monitoring: CBC (hematocrit, hemoglobin) – especially important for EQ; RBC elevation is compound-specific.
• Estrogen monitoring: AI may be required – aromatizes at approximately half the rate of testosterone.
• Blood pressure: Elevated hematocrit from RBC increase is a primary driver of blood pressure risk for EQ cycles.